TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q4 2014. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,082,000 | -42.1% | 655,500 | -0.0% | 0.50% | -29.2% |
| Q1 2019 | $1,868,000 | +27.1% | 655,600 | +2.1% | 0.70% | +18.3% |
| Q4 2018 | $1,470,000 | -68.6% | 641,900 | -45.2% | 0.60% | -41.8% |
| Q3 2018 | $4,688,000 | -24.1% | 1,172,100 | -5.1% | 1.02% | -22.0% |
| Q2 2018 | $6,176,000 | -1.0% | 1,235,300 | +1.9% | 1.31% | -4.1% |
| Q1 2018 | $6,241,000 | +4.3% | 1,211,900 | +3.3% | 1.37% | +5.5% |
| Q4 2017 | $5,984,000 | -17.3% | 1,173,400 | -9.0% | 1.30% | -12.4% |
| Q3 2017 | $7,235,000 | -6.5% | 1,289,600 | 0.0% | 1.48% | -0.9% |
| Q2 2017 | $7,738,000 | +1.1% | 1,289,600 | +0.4% | 1.50% | +4.3% |
| Q1 2017 | $7,653,000 | -5.4% | 1,284,100 | +9.9% | 1.44% | -1.2% |
| Q4 2016 | $8,088,000 | -13.1% | 1,168,800 | +66.1% | 1.45% | -8.3% |
| Q3 2016 | $9,302,000 | +16.3% | 703,600 | -0.2% | 1.58% | +7.2% |
| Q2 2016 | $7,996,000 | -2.7% | 705,100 | 0.0% | 1.48% | +0.8% |
| Q1 2016 | $8,221,000 | +26.1% | 705,100 | +27.2% | 1.47% | +28.5% |
| Q4 2015 | $6,519,000 | +54.2% | 554,300 | +50.0% | 1.14% | +56.9% |
| Q3 2015 | $4,227,000 | -22.5% | 369,500 | +22.4% | 0.73% | -16.1% |
| Q2 2015 | $5,451,000 | +62.7% | 301,800 | +73.3% | 0.87% | +55.9% |
| Q1 2015 | $3,351,000 | -17.6% | 174,100 | -25.1% | 0.56% | +1.1% |
| Q4 2014 | $4,069,000 | – | 232,400 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |